alantolactone has been researched along with Stomach Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, P; He, W; Hong, L; Shen, H; Shen, X; Xia, Y; Zhang, T; Zhao, Y; Zheng, P; Zou, P | 1 |
| Bi, R; Cao, X; He, Y; Kong, Y; Liu, J; Wang, S; Xia, Y | 1 |
2 other study(ies) available for alantolactone and Stomach Neoplasms
| Article | Year |
|---|---|
Potent inhibition of gastric cancer cells by a natural compound via inhibiting TrxR1 activity and activating ROS-mediated p38 MAPK pathway.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Female; Humans; Inula; Lactones; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms, Experimental; p38 Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Sesquiterpenes, Eudesmane; Stomach Neoplasms; Structure-Activity Relationship; Thioredoxin Reductase 1; Tumor Cells, Cultured | 2019 |
Apoptosis-promoting and migration-suppressing effect of alantolactone on gastric cancer cell lines BGC-823 and SGC-7901 via regulating p38MAPK and NF-κB pathways.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Movement; Humans; Inula; Lactones; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Sesquiterpenes, Eudesmane; Signal Transduction; Stomach Neoplasms | 2019 |